Greater magnitude of entheseal microdamage and repair in psoriatic arthritis compared with ankylosing spondylitis on ultrasound

被引:19
|
作者
Alhussain, Fatima Arslan [1 ]
Gunal, Esen Kasapoglu [2 ]
Kurum, Esra [3 ]
Bakirci, Sibel [4 ]
Ozturk, Ayse Bilge [5 ]
McGonagle, Dennis [6 ]
Aydin, Sibel Zehra [4 ,7 ]
机构
[1] Istanbul Medeniyet Univ, Dept Internal Med, Istanbul, Turkey
[2] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey
[3] Univ Calif Riverside, Dept Stat, Riverside, CA 92521 USA
[4] Univ Ottawa, Fac Med, Dept Internal Med, Div Rheumatol, Ottawa, ON, Canada
[5] Koc Univ, Sch Med, Dept Lung & Chest Dis, Div Allergy & Immunol, Istanbul, Turkey
[6] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Dis, Fac Med, Dept Internal Med,Div Rheumatol, Leeds, W Yorkshire, England
[7] Ottawa Hosp Res Inst, Ottawa, ON, Canada
关键词
enthesitis; ultrasound; spondyloarthritis; ankylosing spondylitis; psoriatic arthritis; CLASSIFICATION; ENTHESITIS; CRITERIA;
D O I
10.1093/rheumatology/key238
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. AS and PsA share clinical and immunological features centred on enthesitis. However, a strong association between PsA and preceding injury has been recognized. The aim of this study was to test the hypothesis that the entheseal damage seen by US is commoner in PsA patients than in AS patients. Methods. Seventy-nine AS and 85 PsA patients had US scans of 1640 entheses to calculate entheseal inflammation (hypoechogenicity, thickening and Doppler) and damage scores (calcifications, enthesophytes and erosions). Regression modelling was done to evaluate the effect of diagnoses on outcomes, controlling for age, gender, BMI, clinical enthesitis, HLA-B27, and anti-TNF use. Results. Both inflammation and damage scores on US were correlated with BMI (r = 0.392; r = 0.320) and age (r = 0.308; r = 0.538) (P < 0.001), and men had higher inflammation scores than women [12.3 (7.5) vs 8.9 (7.3), P = 0.001]. In multivariate analysis, despite similar (anti-TNF-treated patients) or slightly less inflammation (anti-TNF-naive patients) in the PsA group, they had 4.22 times more US damage than their counterparts with AS. The difference was even higher in the anti-TNF-naive patients (5.6 times). Conclusion. On US assessment, PsA patients have greater entheseal insertion damage scores compared with AS, suggesting potential differences in tissue repair, immunobiology or response to injury at insertions.
引用
收藏
页码:299 / 303
页数:5
相关论文
共 50 条
  • [1] Ultrasound imaging in psoriatic arthritis and ankylosing spondylitis
    Riente, L.
    Carli, L.
    Delle Sedie, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : S26 - S33
  • [2] Assessment of entheseal injury in Ankylosing spondylitis by ultrasound.
    Alcalde, M
    Cruz, M
    Bordoy, C
    González, L
    Acebes, C
    Sánchez-Pernaute, O
    Armas, JB
    Herrero-Beaumont, G
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S427 - S427
  • [3] SPONDYLOARTHROPATHIES: ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Albert Antonio, Ramon
    ATENCION FARMACEUTICA, 2011, 13 (02): : 99 - 112
  • [4] Secukinumab for ankylosing spondylitis and psoriatic arthritis
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1587 - 1592
  • [5] Spondyloarthropathies: ankylosing spondylitis and psoriatic arthritis
    Bennett, DL
    Ohashi, K
    El-Khoury, GY
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2004, 42 (01) : 121 - +
  • [6] Burden of illness and treatment in psoriatic arthritis compared to rheumatoid arthritis' and ankylosing spondylitis in Germany.
    Huscher, D
    Thiele, K
    Listing, J
    Zink, A
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S610 - S611
  • [8] CARDIOVASCULAR COMPLICATIONS OF ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Tam, L-S
    RHEUMATOLOGY, 2012, 51 : I12 - I12
  • [9] Methotrexate lacks efficacy in the treatment of severe ankylosing spondylitis compared with rheumatoid and psoriatic arthritis
    Ostendorf, B
    Specker, C
    Schneider, M
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1998, 4 (03) : 129 - 136
  • [10] GolimumabIn the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Vicki Oldfield
    Greg L. Plosker
    BioDrugs, 2009, 23 : 125 - 135